Breaking News Instant updates and real-time market news.

2021-02-22 16:56:29 CCL Carnival $25.98 / +1.39 (+5.65%) 16:56 02/22/21 02/22 16:56 02/22/21 16:56	Carnival falls 3% to $25.27 after $1B equity offering	02 Apr 23 Feb
CCL Carnival $25.98 / +1.39 (+5.65%) 02/12/21 Berenberg Carnival downgraded to Sell from Hold at Berenberg 01/26/21 HSBC Carnival downgraded to Reduce from Hold at HSBC 01/22/21 Truist Carnival price target raised to $14 from $11 at Truist 01/12/21 Deutsche Bank Carnival price target raised to $16 from $13 at Deutsche Bank

TODAY'S FREE FLY STORIES

Hot Stocks	Seagen recommends shareholders reject TRC Capital mini-tender offer » 08:13 03/05/21 03/05 08:13 03/05/21 08:13 SGEN Seagen $145.18 / -2.72 (-1.84%) Seagen announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SGEN Seagen $145.18 / -2.72 (-1.84%) 02/18/21 Astellas, Pharma Seagen submit two sBLAs to FDA for Padcev 02/12/21 Seagen, Astellas Pharma announce results from PADCEV pivotal trial 02/12/21 Seagen's Tukysa approved by European Commission for breast cancer 02/11/21 Seagen sees FY21 ADCETRIS sales $675M-$700M SGEN Seagen $145.18 / -2.72 (-1.84%) 02/16/21 RBC Capital Seagen price target lowered to $169 from $186 at RBC Capital 02/12/21 Barclays Seagen price target lowered to $168 from $177 at Barclays 02/12/21 Piper Sandler Seagen price target lowered to $170 from $175 at Piper Sandler 02/01/21 RBC Capital Seagen downgraded to Sector Perform at RBC Capital on valuation SGEN Seagen $145.18 / -2.72 (-1.84%) 02/11/21 Seagen reports Q4 EPS 90c, consensus 86c 10/29/20 Seagen reports Q3 EPS $3.50 vs. (55c) last year SGEN Seagen $145.18 / -2.72 (-1.84%) 02/11/21 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: After-Hours Movers 09/14/20 Fly Intel: Wall Street's top stories for Monday 09/14/20 Fly Intel: Pre-market Movers 04/09/21 Pharma/Biopharma
Earnings	Hurco Companies reports Q1 EPS 10c vs. (13c) last year » 08:12 03/05/21 03/05 08:12 03/05/21 08:12 HURC Hurco Companies $30.85 / -0.95 (-2.99%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings Events HURC Hurco Companies $30.85 / -0.95 (-2.99%) 01/08/21 Hurco Companies reports Q4 EPS (54c) vs. 31c last year 03/11/21 Hurco Companies Inc.
Recommendations	Jamf Holding price target raised to $49 from $45 at RBC Capital » 08:12 03/05/21 03/05 08:12 03/05/21 08:12 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 03/01/21 Jamf acquires security, compliance solutions created by cmdSecurity 02/01/21 Jamf Holding COO, CFO sell 60.7K shares and 6.3K shares in common stock 01/04/21 Jamf Holding announces it is running on more than 20M Apple devices 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 06:39 Today Mizuho Jamf Holding price target raised to $45 from $43 at Mizuho 01/28/21 Piper Sandler Jamf Holding remains a top idea for 2021 at Piper Sandler 01/05/21 Canaccord Jamf Holding metrics 'bode well' for strong Q4, says Canaccord 09/02/20 Canaccord Jamf Holding upside likely in Q3, says Canaccord JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 03/04/21 Jamf Holding sees FY21 revenue $330M-$336M, consensus $316.41M 03/04/21 Jamf Holding sees Q1 revenue $76M-$77M, consensus $72.44M 03/04/21 Jamf Holding reports Q4 EPS (8c), consensus 1c 19 Nov 22 Jul JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 03/04/21 Fly Intel: After-Hours Movers 03/08/21 Jamf Holding
Recommendations	Market undervaluing Durect's alcoholic hepatitis opportunity, says Chardan » 08:12 03/05/21 03/05 08:12 03/05/21 08:12 DRRX Durect $2.05 / -0.13 (-5.96%) Chardan analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events DRRX Durect $2.05 / -0.13 (-5.96%) 03/04/21 Durect in discussions with potential partners for Posimir 03/04/21 Durect discontinues Covid trial due to lack of patients, other treatments 02/02/21 Durect announces FDA approval of POSIMIR 02/02/21 Durect jumps over 40% after FDA posts approval of pain drug DRRX Durect $2.05 / -0.13 (-5.96%) 02/03/21 Jefferies Posimir should not be significant threat to Pacira's Exparel, says Jefferies 02/03/21 Chardan Chardan boosts Durect target to $8 with 'final overhang' removed 02/02/21 Oppenheimer Posimir approval a 'significant positive' for Durect, says Oppenheimer 02/02/21 Roth Capital Roth reiterates $7 target on Durect after 'surprise' FDA approval DRRX Durect $2.05 / -0.13 (-5.96%) 03/04/21 Durect reports Q4 cont ops EPS (4c), consensus (3c) 11/02/20 Durect reports Q3 EPS (5c), consensus (4c) 04 Feb DRRX Durect $2.05 / -0.13 (-5.96%) 11/03/20 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference
Hot Stocks	Virgin Galactic down 7% after Palihapitiya sells 6.2M shares » 08:11 03/05/21 03/05 08:11 03/05/21 08:11 SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) Chamath Palihapitiya,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) 02/25/21 Virgin Galactic CFO Jon Campagna to step down, Doug Ahrens to succeed 02/25/21 Virgin Galactic announces leadership appointments 02/22/21 Virgin Galactic hires Joe Rohde as advisor and 'first Experience Architect' 02/18/21 Virgin Galactic move higher attributed to flight test speculation SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) 03/03/21 BofA Virgin Galactic price target raised to $50 from $35 at BofA 02/26/21 Alembic Global Virgin Galactic downgraded to Neutral from Overweight at Alembic Global 02/26/21 UBS Virgin Galactic price target lowered to $40 from $52 at UBS 02/09/21 UBS Virgin Galactic downgraded to Neutral from Buy at UBS SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) 02/25/21 Virgin Galactic reports Q4 EPS (31c) consensus (31c) 11/05/20 Virgin Galactic reports Q3 EPS (34c), consensus (26c) 06 Aug 03 Jun 20 May SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) 02/18/21 Virgin Galactic tells Seeking Alpha launch speculation 'not true' 02/11/21 Virgin Galactic cites 'good progress' to CNBC after FAA posts notice 10/20/20 Chanos 'joking' when talking 'positively' about space companies, CNBC says SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/26/21 Fly Intel: Pre-market Movers 02/25/21 Fly Intel: After-Hours Movers SPCE Virgin Galactic $30.29 / -1.72 (-5.37%) 02/18/21 Virgin Galactic call volume above normal and directionally bullish 01/29/21 Virgin Galactic call volume above normal and directionally bullish 01/27/21 Virgin Galactic call volume above normal and directionally bullish 01/26/21 Virgin Galactic call volume above normal and directionally bullish

Hot Stocks	Huntington Ingalls appoints Kari Wilkinson as president, Shipbuilding division » 08:11 03/05/21 03/05 08:11 03/05/21 08:11 HII Huntington Ingalls $179.32 / -3.55 (-1.94%) Huntington Ingalls… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options HII Huntington Ingalls $179.32 / -3.55 (-1.94%) 02/26/21 Huntington Ingalls awarded up to $213.9M government contract 02/19/21 Huntington Ingalls awarded $2.99B Navy contract 02/11/21 Huntington Ingalls sees FY21 shipbuilding revenue $8.2B-$8.4B 02/03/21 PMC Capital acquires UniversalPegasus International from Huntington Ingalls HII Huntington Ingalls $179.32 / -3.55 (-1.94%) 01/06/21 Vertical Research Huntington Ingalls downgraded to Hold from Buy at Vertical Research 12/04/20 Alembic Global Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global 10/02/20 JPMorgan Huntington Ingalls price target lowered to $175 from $205 at JPMorgan 10/01/20 Barclays Huntington Ingalls price target lowered to $160 from $190 at Barclays HII Huntington Ingalls $179.32 / -3.55 (-1.94%) 02/11/21 Huntington Ingalls reports Q4 adjusted EPS $4.35, consensus $4.56 11/05/20 Huntington Ingalls sees 2020 shipbuilding revenue $7.9B 11/05/20 Huntington Ingalls reports Q3 EPS $5.45, consensus $4.13 HII Huntington Ingalls $179.32 / -3.55 (-1.94%) 02/11/21 Early notable gainers among liquid option names on February 11th
Hot Stocks	Hanesbrands appoints Tracy Preston general counsel, chief compliance officer » 08:11 03/05/21 03/05 08:11 03/05/21 08:11 HBI Hanesbrands $18.44 / -0.35 (-1.86%) HanesBrands announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options HBI Hanesbrands $18.44 / -0.35 (-1.86%) 02/24/21 Hanesbrands' Champion brand in multi-year pact with the G.O.A.T. 02/10/21 Hanesbrands announces primary licensing pact with Ohio State University 02/09/21 Hanesbrands rises 21.2% 02/09/21 Hanesbrands rises 21.7% HBI Hanesbrands $18.44 / -0.35 (-1.86%) 02/10/21 B. Riley Securities Hanesbrands price target raised to $22 from $19 at B. Riley Securities 02/10/21 Barclays Hanesbrands price target raised to $26 from $16 at Barclays 01/21/21 Deutsche Bank Hanesbrands price target raised to $16 from $14 at Deutsche Bank 12/14/20 Fly Intel: Top five analyst downgrades HBI Hanesbrands $18.44 / -0.35 (-1.86%) 02/09/21 Hanesbrands sees adjusted EPS 24c-27c, consensus 18c 02/09/21 Hanesbrands reports Q4 adjusted EPS 38c, consensus 29c 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open HBI Hanesbrands $18.44 / -0.35 (-1.86%) 02/09/21 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: Wall Street's top stories for Thursday 11/05/20 Fly Intel: Wall Street's top stories at midday 11/05/20 Fly Intel: Pre-market Movers HBI Hanesbrands $18.44 / -0.35 (-1.86%) 02/09/21 Post-earnings call buyer slips into Hanesbrands March 21s 02/09/21 Early notable gainers among liquid option names on February 9th
Recommendations	Purple Innovation price target lowered to $32 from $38 at Wedbush » 08:09 03/05/21 03/05 08:09 03/05/21 08:09 PRPL Purple Innovation $24.42 / -11.76 (-32.50%) Wedbush analyst Seth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 03/04/21 Purple Innovation: Guidance 'true,' QTD not tracking better than guidance 10/19/20 Purple Innovation signs exclusive partnership with Sleep Country Canada PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 08:05 Today Raymond James Purple Innovation price target lowered to $32 from $36 at Raymond James 06:21 Today UBS Purple Innovation price target lowered to $32 from $44 at UBS 01/12/21 B. Riley Securities Purple Innovation price target raised to $41 from $20 at B. Riley Securities 01/12/21 Wedbush Purple Innovation price target raised to $38 from $32 at Wedbush PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 03/04/21 Purple Innovation sees Q1 revenue $160M-$170M, consensus $176.46M 03/04/21 Purple Innovation sees FY21 revenue $840M-$880M, consensus 03/04/21 Purple Innovation reports Q4 adjusted EPS 7c, consensus 11c 11/11/20 Notable companies reporting after market close 10 Sep 15 May PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 11/10/20 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 12/24/20 Purple Innovation call volume above normal and directionally bullish 12/07/20 Unusual call flow in option market yesterday 12/04/20 Unusual call volume in Purple Innovation as shares traded up 4% 12/01/20 Largest borrow rate increases among liquid names
Hot Stocks	Second Sight receives FDA approval for Argus 2s Retinal Prosthesis System » 08:09 03/05/21 03/05 08:09 03/05/21 08:09 EYES Second Sight $1.43 / -0.29 (-16.86%) Second Sight announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate EYES Second Sight $1.43 / -0.29 (-16.86%) 09/22/20 Second Sight resumes early feasibility study of Orion at UCLA EYES Second Sight $1.43 / -0.29 (-16.86%) 04/01/20 H.C. Wainwright Second Sight rating placed under review at H.C. Wainwright 01 May
Hot Stocks	Brickell Biotech to host KOL webinar on the hyperhidrosis market » 08:08 03/05/21 03/05 08:08 03/05/21 08:08 BBI Brickell Biotech $1.17 / + (+0.00%) Brickell Biotech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events BBI Brickell Biotech $1.17 / + (+0.00%) 01/19/21 Brickell announces Japan Phase 3 study results for sofpironium bromide gel 12/07/20 Brickell Biotech doses first patient in second U.S. Phase 3 study 11/18/20 Brickell Biotech announces Japan launch date for sofpironium bromide gel, 5% 10/06/20 Brickell Biotech initiates U.S. Phase 3 program of sofpironium bromide gel, 15% BBI Brickell Biotech $1.17 / + (+0.00%) 09/25/20 Lake Street Approval in Japan validating for Brickell Biotech, says Lake Street 08/28/20 Lake Street Brickell Biotech initiated with a Buy at Lake Street 08/25/20 Oppenheimer Brickell Biotech initiated with an Outperform at Oppenheimer 23 Oct 18 Jun 03/10/21 Global Life Sciences Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/09/21 Brickell Biotech - BBI

Hot Stocks	Fathom acquires real estate brokerage business of Red Barn Real Estate » 08:08 03/05/21 03/05 08:08 03/05/21 08:08 FTHM Fathom $34.78 / -5.22 (-13.05%) Fathom Holdings announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate FTHM Fathom $34.78 / -5.22 (-13.05%) 02/16/21 Fathom, Zavvie partner for residential real estate service 02/10/21 Fathom signs agreement to acquire technology platform Naberly Solutions 11/05/20 Fathom to acquire Verus Title, terms not disclosed FTHM Fathom $34.78 / -5.22 (-13.05%) 02/10/21 Roth Capital Roth raises Fathom target to $52, sees 'multifold benefits' from Naberly deal 02/09/21 DA Davidson Fathom initiated with a Buy at DA Davidson 01/25/21 Roth Capital Fathom price target raised to $50 from $40 at Roth Capital 12/28/20 Roth Capital Fathom price target raised to $40 from $28 at Roth Capital 28 Jul
Hot Stocks	Immutep expands Part B of TACTI-002 Phase II study » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 IMMP Immutep $2.41 / -0.2 (-7.66%) Immutep is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly IMMP Immutep $2.41 / -0.2 (-7.66%) 01/27/21 Immutep announces DSMB recommends Phase II trial advance with enrollment 01/21/21 Immutep announces GlaxoSmithKline discontinuation of GSK2831781 trial 01/06/21 Immutep completes recruitment in TACTI-002 phase 3 study trial 12/29/20 Immutep secures U.S. patent for Eftilagimod Alpha IMMP Immutep $2.41 / -0.2 (-7.66%) 01/26/21 Alliance Global Partners Immutep price target raised to $6 from $5 at Alliance Global Partners 12/14/20 Maxim Maxim doubled Immutep price target after breast cancer update 11/11/20 Maxim Immutep price target raised to $4 from $2 at Maxim 09/22/20 Top five analyst initiations IMMP Immutep $2.41 / -0.2 (-7.66%) 12/30/20 Fly Intel: Pre-market Movers 12/29/20 Fly Intel: After-Hours Movers
Recommendations	Joint Corp. price target raised to $54 from $28 at Maxim » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 JYNT Joint Corp. $44.28 / -4.77 (-9.72%) Maxim analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 01/05/21 Joint Corp. acquires two regional developer territories for $2.4M JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 02/25/21 B. Riley Securities Joint Corp. price target raised to $47 from $26 at B. Riley Securities 01/06/21 Craig-Hallum Joint Corp. price target raised to $38 from $26 at Craig-Hallum 01/04/21 Lake Street Joint Corp. price target raised to $35 from $25 at Lake Street 11/06/20 B. Riley Securities Joint Corp. price target raised to $26 from $22 at B. Riley Securities JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 03/04/21 Joint Corp. sees FY21 revenue $73M-$77M , consensus $72.23M 03/04/21 Joint Corp. reports Q4 EPS 72c, consensus 14c 11/05/20 Joint Corp. reports Q3 EPS 11c, consensus 2c 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	Allied Esports confirms proposal from Bally's to acquire the company for $100M » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) , BALY Bally's $52.30 / -8.27 (-13.65%) Allied Esports… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events AESE BALY AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 08:00 Today Allied Esports Entertainment Inc trading halted, news dissemination 01/19/21 Allied Esports Entertainment sells World Poker Tour to Element Partners 01/13/21 Allied Esports, HyperX renew naming rights agreement for HyperX Esports Arena 12/17/20 Allied Esports Entertainment, Trovo announce battle royale Esports tournament BALY Bally's $52.30 / -8.27 (-13.65%) 03/04/21 Bally's becomes authorized sports betting operator of the NBA 03/04/21 Bally's CEO seeing 'markedly stronger consumer demand' in January, February 02/22/21 Bally's submits proposal to develop casino in Richmond, Virginia 02/18/21 Bally's becomes official sports betting partner of The National Hockey League AESE BALY AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 06/08/20 Alliance Global Partners Alliance Global says Allied Esports refinancing eliminates near-term overhang 05/15/20 Stephens Allied Esports Entertainment price target lowered to $4 from $5 at Stephens 05/06/20 Alliance Global Partners Allied Esports Entertainment initiated with a Buy at Alliance Global Partners BALY Bally's $52.30 / -8.27 (-13.65%) 06:55 Today Stifel Stifel upgrades Bally's to Buy after 'overplayed' post-earnings dip 05:30 Today Stifel Bally's upgraded to Buy from Hold at Stifel 02/24/21 Truist Bally's price target raised to $80 from $65 at Truist 02/09/21 Stifel Bally's price target raised to $60 from $50 at Stifel BALY BALY Bally's $52.30 / -8.27 (-13.65%) 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings BALY BALY Bally's $52.30 / -8.27 (-13.65%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says AESE BALY AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 02/01/21 Fly Insider:Allied Esports,Applied Optoelectronics among notable insider trades BALY Bally's $52.30 / -8.27 (-13.65%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test 03/15/21 33rd Annual Roth Virtual Conference
Recommendations	Outfront Media price target raised to $24 from $22 at Barrington » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 OUT Outfront Media $21.47 / -0.305 (-1.40%) Barrington analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly OUT Outfront Media $21.47 / -0.305 (-1.40%) 03/02/21 Citi Outfront Media price target raised to $25 from $21 at Citi 11/12/20 Citi Outfront Media price target raised to $21 from $18 at Citi 11/02/20 Morgan Stanley Lamar Advertising upgraded at Morgan Stanley with recovery not priced in 09/25/20 Citi Outfront Media upgraded to Buy from Neutral at Citi OUT Outfront Media $21.47 / -0.305 (-1.40%) 02/25/21 Outfront Media reports Q4 EPS (2c), consensus (3c) 11/04/20 Outfront Media reports Q3 adjusted EPS (14c), consensus (18c) 23 Feb OUT Outfront Media $21.47 / -0.305 (-1.40%) 09/25/20 Fly Intel: Pre-market Movers

Hot Stocks	Keros presents results from preclinical studies of KER-050, ALK2 Inhibitors » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) Keros Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) 12/21/20 Keros Therapeutics added to the Nasdaq Biotechnology Index 12/17/20 Keros Therapeutics appoints Mary Ann Gray to board of directors 12/07/20 Keros Therapeutics presents results from ALK2 Inhibitor program 10/20/20 Keros Therapeutics doses first participants in Phase 2 trial of KER-050 KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) 12/08/20 SVB Leerink Keros Therapeutics price target raised to $80 from $42 at SVB Leerink 12/08/20 H.C. Wainwright Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright 12/08/20 Piper Sandler Keros Therapeutics price target raised to $95 from $75 at Piper Sandler 11/18/20 Piper Sandler Keros Therapeutics price target raised to $75 from $55 at Piper Sandler 13 Nov 08 Apr KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) 11/13/20 Fly Intel: Pre-market Movers
Recommendations	Cooper Companies price target raised to $415 from $375 at Raymond James » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 COO Cooper Companies $371.84 / -9.125 (-2.40%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events COO Cooper Companies $371.84 / -9.125 (-2.40%) 02/03/21 Cooper Companies, EssilorLuxottica enter JV to acquire SightGlass Vision 10/09/20 CooperVision presents six-year data from MiSight 1 day study COO Cooper Companies $371.84 / -9.125 (-2.40%) 06:52 Today Baird Cooper Companies price target raised to $384 from $351 at Baird 06:19 Today Citi Cooper Companies price target raised to $378 from $355 at Citi 02/11/21 Piper Sandler Cooper Companies price target raised to $435 from $370 at Piper Sandler 01/25/21 Wells Fargo Cooper Companies price target raised to $445 from $415 at Wells Fargo COO Cooper Companies $371.84 / -9.125 (-2.40%) 03/04/21 Cooper Companies sees FY21 EPS $12.90-$13.10, consensus $12.54 03/04/21 Cooper Companies reports Q1 EPS $3.17, consensus $2.78 12/03/20 Cooper Companies sees Q1 EPS $2.66-$2.86, consensus $2.88 12/03/20 Cooper Companies reports Q4 EPS $3.16, consensus $3.09 COO Cooper Companies $371.84 / -9.125 (-2.40%) 03/04/21 Fly Intel: After-Hours Movers 03/17/21 The Cooper Companies Inc.
Hot Stocks	PriceSmart announces February net merchandise sales up 1.3% to $258.7M » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 PSMT PriceSmart $91.39 / -3.43 (-3.62%) PriceSmart announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PSMT PriceSmart $91.39 / -3.43 (-3.62%) 02/05/21 PriceSmart announces January net merchandise sales up 5.2% to $267.1M 02/03/21 PriceSmart to open ninth warehouse club in Colombia 01/08/21 PriceSmart reports fiscal YTD net merchandise sales up 6.1% to $1.211B 01/08/21 PriceSmart announces December net merchandise sales up 2.8% to $372.6M PSMT PriceSmart $91.39 / -3.43 (-3.62%) 05/08/20 Scotiabank Scotiabank downgrades PriceSmart amid COVID-19 restrictions 05/08/20 Scotiabank PriceSmart downgraded to Sector Perform from Outperform at Scotiabank PSMT PriceSmart $91.39 / -3.43 (-3.62%) 01/07/21 PriceSmart reports Q1 EPS 90c, two estimates 68c 10/29/20 PriceSmart reports Q4 EPS 65c vs. 67c last year PSMT PriceSmart $91.39 / -3.43 (-3.62%) 01/07/21 Fly Intel: After-Hours Movers
Recommendations	NGM Biopharmaceuticals price target raised to $44 from $39 at Chardan » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) Chardan analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 03/02/21 NGM Biopharmaceuticals initiates expansion of Phase 1b study of NGM120 12/09/20 NGM Biopharmaceuticals announces NGM438 featured during R&D Day 11/13/20 NGM Biopharmaceuticals presents Phase 1 safety, PK data for NGM621 10/19/20 NGM announces immuno-oncology development candidate NGM707 NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 02/09/21 Goldman Sachs NGM Biopharmaceuticals price target raised to $38 from $28 at Goldman Sachs 01/08/21 Raymond James NGM Biopharmaceuticals price target raised to $50 from $32 at Raymond James 01/05/21 Stifel NGM Biopharmaceuticals named a top pick, price target boosted to $43 at Stifel 12/21/20 Citi NGM Biopharmaceuticals price target raised to $44 from $28 at Citi NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 03/04/21 NGM Biopharmaceuticals reports Q4 EPS (40c), consensus (47c) 11/12/20 NGM Biopharmaceuticals reports Q3 EPS (43c), consensus (38c) 06 Jan NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 01/04/21 Fly Intel: After-Hours Movers
Recommendations	Purple Innovation price target lowered to $32 from $36 at Raymond James » 08:05 03/05/21 03/05 08:05 03/05/21 08:05 PRPL Purple Innovation $24.42 / -11.76 (-32.50%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 03/04/21 Purple Innovation: Guidance 'true,' QTD not tracking better than guidance 10/19/20 Purple Innovation signs exclusive partnership with Sleep Country Canada PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 06:21 Today UBS Purple Innovation price target lowered to $32 from $44 at UBS 01/12/21 B. Riley Securities Purple Innovation price target raised to $41 from $20 at B. Riley Securities 01/12/21 Wedbush Purple Innovation price target raised to $38 from $32 at Wedbush 12/16/20 Truist Purple Innovation initiated with a Buy at Truist PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 03/04/21 Purple Innovation sees Q1 revenue $160M-$170M, consensus $176.46M 03/04/21 Purple Innovation sees FY21 revenue $840M-$880M, consensus 03/04/21 Purple Innovation reports Q4 adjusted EPS 7c, consensus 11c 11/11/20 Notable companies reporting after market close 10 Sep 15 May PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 11/10/20 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 12/24/20 Purple Innovation call volume above normal and directionally bullish 12/07/20 Unusual call flow in option market yesterday 12/04/20 Unusual call volume in Purple Innovation as shares traded up 4% 12/01/20 Largest borrow rate increases among liquid names

Hot Stocks	Sonim partners with FIH Mobile for next generation feature phones » 08:04 03/05/21 03/05 08:04 03/05/21 08:04 SONM Sonim $0.90 / -0.1102 (-10.91%) , HNHPF Hon Hai Precision $0.00 / + (+0.00%) , QCOM Qualcomm $127.67 / -3.93 (-2.99%) Sonim Technologies (SONM)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SONM HNHPF QCOM SONM Sonim $0.90 / -0.1102 (-10.91%) 03/03/21 Sonim, Energy Electronics sign new Distribution agreement in North America 01/25/21 Sonim announces partnership with Syndico 01/20/21 Sonim receives Nasdaq compliance extension 12/22/20 Sonim announces software development, asset purchase agreement with Coforge HNHPF Hon Hai Precision $0.00 / + (+0.00%) 02/16/21 Amazon to build device manufacturing line in India 01/06/21 Foxconn reports December revenue up 32.3% y/y to NT$13.78B QCOM Qualcomm $127.67 / -3.93 (-2.99%) 03/03/21 Lantronix announces Mobile HDK featuring Qualcomm Snapdragon 888 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 02/09/21 Globalstar announces inclusion of Band n53 in Qualcomm's X65 modem 02/03/21 Qualcomm down 7% to $151.01 after Q1 earnings, Q2 outlook SONM HNHPF QCOM SONM Sonim $0.90 / -0.1102 (-10.91%) 12/16/20 B. Riley Securities Sonim transferred with Buy rating at B. Riley Securities 03/16/20 Lake Street Sonim price target lowered to $2 from $3 at Lake Street HNHPF Hon Hai Precision $0.00 / + (+0.00%) QCOM Qualcomm $127.67 / -3.93 (-2.99%) 03/04/21 Fly Intel: Top five analyst upgrades 03/04/21 JPMorgan Qualcomm price target lowered to $170 from $185 at JPMorgan 03/04/21 Piper Sandler Qualcomm upgraded to Overweight from Neutral at Piper Sandler 02/10/21 JPMorgan China mobile shipments data point to 'robust' Apple demand, says JPMorgan SONM QCOM SONM Sonim $0.90 / -0.1102 (-10.91%) 02/23/21 Sonim regains compliance with Nasdaq listing requirements 11/11/20 Sonim reports Q3 EPS (10c), consensus (19c) QCOM Qualcomm $127.67 / -3.93 (-2.99%) 02/03/21 Qualcomm sees Q2 EPS $1.55-$1.75, consensus $1.57 02/03/21 Qualcomm reports Q1 EPS $2.17, consensus $2.10 02/03/21 Notable companies reporting after market close 11/04/20 Qualcomm sees Q1 adjusted EPS $1.95-$2.15, consensus $1.68 05 Jun HNHPF QCOM HNHPF Hon Hai Precision $0.00 / + (+0.00%) 02/26/21 Foxconn to manufacture Fire TV Stick devices for Amazon in India, Nikkei says 02/11/21 Startup developing new devices to be sold under BlackBerry brand, Nikkei says 02/08/21 Foxconn-backed Byton could go public via SPAC deal, Reuters reports 01/14/21 Foxconn unit signs JV agreement with Geely Holding, DigiTimes reports QCOM Qualcomm $127.67 / -3.93 (-2.99%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports 02/12/21 Qualcomm expresses concern over Nvidia's $40B Arm takeover, CNBC reports HNHPF QCOM HNHPF Hon Hai Precision $0.00 / + (+0.00%) 12/05/20 Week in review: How Trump's policies moved stocks QCOM Qualcomm $127.67 / -3.93 (-2.99%) 03/04/21 Snowflake, Qualcomm upgrades among today's top calls on Wall Street 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Fly Intel: What to watch in Nvidia earnings report 02/12/21 Fly Intel: Wall Street's top stories for Friday 03/15/21 33rd Annual Roth Virtual Conference 04/28/21 Qualcomm - QCOM 03/10/21 Qualcomm Inc. QCOM QCOM Qualcomm $127.67 / -3.93 (-2.99%) 12/07/20 Qualcomm call buyer realizes 32% same-day gains 12/04/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Early notable gainers among liquid option names on November 11th
Hot Stocks	QLHC discontinues testing of Aerpio's razuprotafib in I-SPY COVID trial » 08:04 03/05/21 03/05 08:04 03/05/21 08:04 ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) Quantum Leap Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) 01/05/21 Aerpio Pharmaceuticals Inc trading resumes 01/05/21 Aerpio Pharmaceuticals to resume trading at 4:30 p.m. ET 01/05/21 Aerpio Pharmaceuticals to explore, review strategic alternatives 01/05/21 Aerpio Pharmaceuticals Inc trading halted, news pending ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) 12/14/20 H.C. Wainwright Aerpio Pharmaceuticals price target lowered to $1.50 from $2 at H.C. Wainwright 12/09/20 Fly Intel: Top five analyst initiations 12/09/20 BTIG Aerpio Pharmaceuticals initiated with a Buy at BTIG 06/25/20 H.C. Wainwright Aerpio Pharmaceuticals price target raised to $1.50 from $1 at H.C. Wainwright ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) 01/05/21 Fly Intel: After-Hours Movers
Downgrade	Dexus downgraded to Hold from Buy at Jefferies » 08:03 03/05/21 03/05 08:03 03/05/21 08:03 DXSPF Dexus $0.00 / + (+0.00%) Jefferies analyst Sholto… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DXSPF Dexus $0.00 / + (+0.00%) 10/30/20 JPMorgan Dexus downgraded to Neutral from Overweight at JPMorgan
Earnings	Global Partners reports Q4 EPS 6c, consensus (17c) » 08:03 03/05/21 03/05 08:03 03/05/21 08:03 GLP Global Partners $20.24 / -0.18 (-0.88%) Reports Q4 revenue $2.2B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GLP Global Partners $20.24 / -0.18 (-0.88%) 01/26/21 Global Partners boosts quarterly cash distribution to 55c per unit 12/14/20 Global Partners buys retail fuel, convenience stores from Consumers Petroleum 10/26/20 Global Partners boosts quarterly dividend to 50c per share GLP Global Partners $20.24 / -0.18 (-0.88%) 03/24/20 Barclays Global Partners upgraded to Equal Weight from Underweight at Barclays GLP Global Partners $20.24 / -0.18 (-0.88%) 11/05/20 Global Partners reports Q3 EPS 47c, consensus 11c 10:00 Today Global Partners - GLP
Downgrade	Senseonics downgraded to Underperform from Market Perform at Raymond James » 08:02 03/05/21 03/05 08:02 03/05/21 08:02 SENS Senseonics $2.69 / -0.48 (-15.14%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SENS Senseonics $2.69 / -0.48 (-15.14%) 02/01/21 Ascensia commences sales, marketing activities for Eversense XL CGM 01/21/21 Senseonics Holder Masters reports 5.89% active stake 01/19/21 Senseonics announces positive coverage decision for Eversense CGM 10/05/20 Senseonics submits PMA application for 180-Day Eversense System to the FDA SENS Senseonics $2.69 / -0.48 (-15.14%) 04:51 Today Raymond James Senseonics downgraded to Underperform from Market Perform at Raymond James 01/20/21 BTIG BTIG cuts Senseonics to Neutral, sees no fundamental reason for rapid rise 01/20/21 BTIG Senseonics downgraded to Neutral from Buy at BTIG 01/20/21 Craig-Hallum Senseonics downgraded to Sell at Craig-Hallum SENS Senseonics $2.69 / -0.48 (-15.14%) 03/04/21 Senseonics sees FY21 revenue $12M-$15M, consensus $13.15M 03/04/21 Senseonics reports Q4 EPS (41c), consensus (9c) 12/23/20 Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M 12/23/20 Senseonics sees Q4 revenue $3.5M, consensus $2.49M 22 Jan SENS Senseonics $2.69 / -0.48 (-15.14%) 01/22/21 Fly Intel: Pre-market Movers 12/24/20 Fly Intel: Pre-market Movers SENS Senseonics $2.69 / -0.48 (-15.14%) 03/04/21 Senseonics options imply 28.4% move in share price post-earnings 02/08/21 Unusually active option classes on open February 8th 01/06/21 Largest borrow rate increases among liquid names 12/24/20 Unusually active option classes on open December 24th

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: February 2021 Government Event
Today at 08:30

Employment Situation: Average Workweek: February 2021 Government Event
Today at 08:30

Employment Situation--Private Payrolls M/M: February 2021 Government Event
Today at 08:30

International Trade in Goods Balance: January 2021 Government Event
Today at 08:30

Manufacturing Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Participation Rate: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings M/M: February 2021 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: February 2021 Government Event
AT
Today at 08:30

Atlantic Power - AT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Carnival falls 3% to $25.27 after $1B equity offering

TODAY'S FREE FLY STORIES

Get Full Fly Access